The APP/PS1 mouse, a well-studied and validated AD mouse model21,25, also exhibited an increase of ASM activity in plasma but, as was the case in patients, no significant differences in plasma ceramides with age (Supplementary Fig. 1c, d). Here, SMPD1 is linked to Alzheimer disease.